| 000 | 01641 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513200713.0 | ||
| 264 | 0 | _c20000210 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0268-1161 | ||
| 024 | 7 |
_a10.1093/humrep/15.1.43 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeckers, N G | |
| 245 | 0 | 0 |
_aFollicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. _h[electronic resource] |
| 260 |
_bHuman reproduction (Oxford, England) _cJan 2000 |
||
| 300 |
_a43-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChorionic Gonadotropin _xadministration & dosage |
| 650 | 0 | 4 |
_aCorpus Luteum _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertilization in Vitro |
| 650 | 0 | 4 |
_aFollicular Phase _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteal Phase _xphysiology |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 |
_aLuteolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aMenotropins _xadministration & dosage |
| 650 | 0 | 4 | _aOvulation Induction |
| 650 | 0 | 4 |
_aPituitary Gland _xphysiology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aProgesterone _xblood |
| 650 | 0 | 4 |
_aTriptorelin Pamoate _xadministration & dosage |
| 700 | 1 | _aLaven, J S | |
| 700 | 1 | _aEijkemans, M J | |
| 700 | 1 | _aFauser, B C | |
| 773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 15 _gno. 1 _gp. 43-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/humrep/15.1.43 _zAvailable from publisher's website |
| 999 |
_c10566946 _d10566946 |
||